-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2019 to Q1 2023.
- Ambrx Biopharma Cayman, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2023 was $0, a 100% decline year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $963,000.
- Ambrx Biopharma Cayman, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $0, a 100% decline from 2020.
- Ambrx Biopharma Cayman, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $7,000.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)